EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low Expression Loci and the Use of Pronase in Flow Cytometry Crossmatch

Cláudia Silva, Paula Aires, Paula Santo, Paula Xavier

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.03.075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Cláudia Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Português Do Sangue E Da Transplantação-Área Transplantação, Porto, Portugal. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pronase treatment of lymphocytes has been used to improve the specificity and sensitivity of flow cytometric crossmatch, especially B-cell flow cytometric crossmatch, due to the presence of Fc receptors on the cell surface. Some limitations have been reported in the literature: false negatives due to the reduction of major histocompatibility complex expression and false-positive T cells in HIV+ patients due to exposure to cryptic epitopes. This study aimed to evaluate the effect of pronase in our assays, using untreated and treated cells with 2.35 U/mL of pronase to improve flow cytometric crossmatch specificity and sensitivity. The study was carried out with donor-specific IgG antibodies (DSAs) to low expression loci (HLA-C, -DQ, or -DP) because, in our laboratory practice, patients with virtual crossmatch (LABScreen single antigen assays) to DSA against antigen HLA-A, B, and DR are excluded from cellular crossmatch. Our results showed that, for T-cell flow cytometry crossmatch (FCXM), a cutoff value of 1171 median fluorescence intensity (MFI), an area under the curve (AUC) of 0.926 (P < .0001), and 0.834 (P < .0001), a sensitivity of 100% and 85.7%, and a specificity of 77.5% and 74.4%, without and with pronase treatment, respectively. For B-cell FCXM without pronase treatment, the best cutoff was 2766 MFI, an AUC of 0.731 (P < .0001), a sensitivity of 69.6%, and a specificity of 66.7%, whereas for B cells treated with pronase, the cutoff value was 4496 MFI, an AUC of 0.852 (P < .0001), a sensitivity of 86.4%, and a specificity of 77.8%. Our analysis of 128 FCXM showed a better performance using the untreated lymphocytes for FCXM with the prerequisite of a higher cutoff value (≈5000 MFI) to reach a better sensitivity and specificity due to the loss of HLA expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansFlow CytometryPronaseHLA AntigensHistocompatibility TestingGraft RejectionIsoantibodies

Substanzen

PronaseHLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Instituto Português Do Sangue E Da Transplantação-Área Transplantação, Porto, Portugal.
  • Instituto Português Do Sangue E Da Transplantação-Área Transplantação, Porto, Portugal. Electronic address: paula.xavier@ipst.min-saude.pt.

Zitieren

APA

Silva, C., Aires, P., Santo, P., & Xavier, P. (2023). Low Expression Loci and the Use of Pronase in Flow Cytometry Crossmatch. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.03.075

Vancouver

Silva C, Aires P, Santo P, Xavier P. Low Expression Loci and the Use of Pronase in Flow Cytometry Crossmatch. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.03.075

BibTeX
@article{Silva2023,
  author = {Silva, Cláudia and Aires, Paula and Santo, Paula and Xavier, Paula},
  title = {Low Expression Loci and the Use of Pronase in Flow Cytometry Crossmatch},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.03.075}
}
Kostenlos starten →